Investment NewsTrading News

BioProcure and Prendio Articulate Strategic Enhance Investment From Primus Capital

Press Release

Oct 18, 2023 08:00 EDT

Investment will additional velocity up company growth and innovation across all services and products and choices

BOSTON, October 18, 2023 (

Prendio, the leading provider of cloud-based (Gadget-as-a-Service) eProcurement software and vendor marketplace solutions for existence sciences, and sister company BioProcure, the chief in receive-to-pay fortify services and products for biotech, maintain on the unusual time launched a fundamental growth equity funding from Primus Capital (“Primus”). Primus’ funding will fortify continued organic growth, expansion into extra existence sciences markets, and additional innovation and product growth. 

Since 2007, Prendio and BioProcure maintain been committed to the mission of simplifying and optimizing procurement for existence science organizations, enabling them to focal level on their core study and growth activities. With an immense vendor network of more than 10,000 leading suppliers, Prendio and BioProcure’s constructed-in receive-to-pay solutions assist streamline procurement processes, enhance vendor collaboration, and lift financial innovation and efficiency for excessive-growth existence science companies of all phases.

“We’ve spent over 15 years serving to leading biotech companies save time and money to velocity up study and growth as they strive to raise very well-known therapies to the field. Prendio and BioProcure are overjoyed to partner with Primus to velocity up our growth and magnify the mission-serious fortify we raise to our possibilities,” mentioned Vincent Bologna, Co-Founder and CEO of Prendio and BioProcure. “Primus’ funding, combined with their deep SaaS abilities and precious substitute abilities, will allow us to additional velocity up the growth of our leading existence science eProcurement platform and service choices.”

Phil Molner, Managing Accomplice of Primus, mentioned, “Prendio and BioProcure maintain been pioneers in setting up substitute-leading software and outsourced-services and products solutions specifically designed to meet the distinctive receive-to-pay needs of the biotech and existence sciences industries. We are overjoyed to partner with the founders and management team at Prendio-BioProcure to continue their monitor file of innovation and growth serving these serious substitute sectors.” 

Aeris Companions LLC served as the uncommon financial handbook to Prendio and BioProcure. Latham & Watkins LLP served as true handbook to Prendio and BioProcure, and Goodwin Proctor LLP served as true handbook to Primus Capital. 

About Prendio

Prendio is an substitute-leading, cloud-based eProcurement resolution created specifically for the existence science vertical. Constructed by a team of substitute professionals with over 50 combined years of abilities in biotech procurement, lab management, and finance, the Prendio software became designed to alleviate the anxiety sides felt by study teams combating cumbersome and inefficient receive-to-pay systems. Prendio is an more cost-effective, intuitive, and scalable resolution designed to velocity up the growth of existence science teams all over. For more recordsdata, test with 

About BioProcure

Since 2007, BioProcure has been instrumental to the success of many of of emerging and established existence science companies worldwide. By offering procurement services and products, accounts payable fortify, and diverse administrative assistance to analyze organizations, the BioProcure team has succeeded in securing billions of dollars in payment financial savings for the biotech study organizations they wait on, and relieving lab teams of endless hours of administrative work, permitting them to speculate more of their time and funding into their science and force discovery sooner. For more recordsdata, test with

Supply: Primus Capital

Read Extra

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button